Clinical Trial

Coffee Intake Biomarker Validation and Association With Respiratory Diseases

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This proposed project aims to identify and validate biomarkers of coffee exposure in the Singapore population, and assess the association between coffee consumption (via biomarker measurements) and risk of respiratory diseases in a prospective multi-ethnic cohort in Singapore. Specific Aim 1: To identify and quantify urinary/serum metabolite changes that are associated with coffee consumption in a dose-response intervention study.
Trial Details
NCT Number NCT07391696
Lead Sponsor National University of Singapore
Conditions Coffee
Enrollment 100 participants
Start Date 2020-10-01
Primary Completion 2022-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-06